Back
Aquestive Therapeutics Vs. Geovax Labs Industry Stock Comparison
Buy
63
AQST
Aquestive Therapeutics
Last Price:
5.15
Seasonality Move:
-7.48%
Sell
18
GOVX
Geovax Labs
Last Price:
1.80
Seasonality Move:
-5.24%
Buy
63
Aquestive Therapeutics (AQST)
is a Buy
Is Aquestive Therapeutics a Buy, Sell or Hold?
- The current Aquestive Therapeutics [AQST] share price is $5.15. The Score for AQST is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- AQST is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
18
Geovax Labs (GOVX)
is a Sell
Is Geovax Labs a Buy, Sell or Hold?
- The current Geovax Labs [GOVX] share price is $1.80. The Score for GOVX is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- GOVX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
AQST Stock Price Chart
What is Aquestive Therapeutics's stock price today?
-
The Aquestive Therapeutics share price today is $5.15
The current trend is moderately bearish and AQST is experiencing selling pressure, which indicates risk of future bearish movement.
GOVX Stock Price Chart
What is Geovax Labs's stock price today?
-
The Geovax Labs share price today is $1.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GOVX is experiencing slight selling pressure.
AQST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 50.39 | Buy |
| Chaikin Money Flow: | -1600841 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.78 - 5.4) | Buy |
| Bollinger Bands (100): | (3.01 - 5.03) | Buy |
GOVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 35.08 | Sell |
| Chaikin Money Flow: | -214490 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.96 - 2.2) | Sell |
| Bollinger Bands (100): | (1.53 - 4.27) | Sell |
AQST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.49 | Sell |
| 20-day SMA: | 5.16 | Sell |
| 50-day SMA: | 4.89 | Buy |
| 200-day SMA: | 3.78 | Buy |
| 8-day EMA: | 5.39 | Sell |
| 20-day EMA: | 5.23 | Sell |
| 50-day EMA: | 4.84 | Buy |
| 200-day EMA: | 3.78 | Buy |
GOVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.99 | Sell |
| 20-day SMA: | 2.05 | Sell |
| 50-day SMA: | 2.88 | Sell |
| 200-day SMA: | 2.52 | Sell |
| 8-day EMA: | 1.97 | Sell |
| 20-day EMA: | 2.12 | Sell |
| 50-day EMA: | 2.52 | Sell |
| 200-day EMA: | 10.3 | Sell |
Aquestive Therapeutics Earnings Growth & AQST Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.12 per share.
Geovax Labs Earnings Growth & GOVX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aquestive Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Geovax Labs Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||